Introduction
Since the EU Medical Device Regulation took full effect, the clinical evaluation report has become one of the most scrutinized documents in a medical device technical file. It's also one of the most labor-intensive to produce well, which has turned "clinical evaluation report specialist," or CER specialist, into a recognizable role within medical device regulatory and clinical affairs functions, even though it doesn't always carry that exact title. Understanding what the role actually involves, and how it differs from adjacent regulatory and clinical roles, is useful both for people considering a move into it and for anyone trying to understand who they're working with on a device submission.
At its core, the job is about building and defending the clinical evidence case for a device's safety, performance, and benefit-risk profile, and keeping that case current for as long as the device stays on the market. It sits at the intersection of regulatory strategy, clinical and scientific literature review, and ongoing post-market data, which makes it a genuinely cross-functional role even when it reports into a regulatory affairs or clinical affairs department.
What a CER Specialist Actually Produces
The clinical evaluation report itself is a structured document, built according to the methodology set out in MEDDEV 2.7/1 Revision 4 and now embedded in MDR Annex XIV, that lays out the clinical evidence supporting a device, evaluates whether that evidence demonstrates conformity with the general safety and performance requirements, and documents the benefit-risk determination. For many devices, especially those without extensive dedicated clinical investigations of their own, a significant part of the evidence comes from a systematic literature review covering the device itself, equivalent devices, and the broader state of the art for that device category or clinical use.
Producing that report well means running a genuinely systematic literature search with a defined protocol, screening and appraising the quality of the studies that come back, and synthesizing the results into a coherent clinical evidence narrative rather than a loosely organized bibliography. Where equivalence to another device is being claimed, the specialist has to build and justify the technical, biological, and clinical equivalence argument in enough depth to survive notified body scrutiny, which has gotten considerably more demanding under MDR than it was under the prior Medical Device Directive.
How the Role Connects to Post-Market Surveillance
A clinical evaluation report is never really finished once a device is on the market. MDR requires that the clinical evaluation be actively maintained and updated throughout the device's lifecycle, informed by ongoing post-market clinical follow-up data, post-market surveillance findings, complaint trends, and any new published literature. That means a CER specialist's work doesn't stop at initial submission; it continues as a standing responsibility to monitor the literature and incoming post-market data and to determine, on a defined schedule, whether the clinical evaluation conclusions still hold.
This is where the role overlaps most closely with post-market clinical follow-up work and with broader post-market surveillance functions. On a given device program these can be separate specialists working in close coordination, or in smaller device companies, the same person may handle both the periodic PMCF plan and the clinical evaluation update that incorporates its results. Either way, understanding how PMCF data flows into a clinical evaluation update, and what triggers an earlier-than-scheduled reassessment, such as a safety signal or a new competitor product changing the state of the art, is core to doing the job well.
The Skill Set This Role Actually Requires
The strongest CER specialists combine a few distinct capabilities that don't always live in the same person by default. The first is genuine literature review and critical appraisal skill: knowing how to construct a systematic search strategy, apply inclusion and exclusion criteria consistently, and assess study quality and relevance rather than simply compiling whatever a database search returns. The second is regulatory fluency, specifically familiarity with MEDDEV 2.7/1 Revision 4, MDR Annex XIV, and how notified bodies have been applying both in practice, since the methodology is detailed and reviewers hold submissions to it closely.
The third, and often underrated, capability is scientific writing. A clinical evaluation report has to present a defensible, well-reasoned argument that a notified body reviewer, who may not be a specialist in the device's specific clinical area, can follow and evaluate. That means writing clearly about clinical data, equivalence arguments, and benefit-risk conclusions in a way that holds up to close reading, not just summarizing source material.
Background-wise, people land in this role from a few directions: clinical research or medical writing backgrounds who build regulatory fluency on the job, regulatory affairs professionals who develop deep literature review skill through repeated CER work, and increasingly, dedicated clinical evaluation consultancies and contract research organizations that specialize in MDR-compliant CERs and train specialists specifically for this function.
Where These Roles Sit Organizationally
In larger medical device companies, CER work is often done by an internal team, sometimes sitting within regulatory affairs and sometimes within a dedicated clinical affairs function, with close working relationships to both. In smaller device companies without the volume of submissions to justify a dedicated internal specialist, this work is frequently outsourced to specialized consultancies, which has created a parallel hiring market at firms that do CER work across many client device programs rather than one internal portfolio. Both paths are legitimate ways into the role, and experience at a CER-focused consultancy, working across a range of device types and therapeutic areas, can actually build broader pattern recognition faster than staying within one company's device portfolio.
Where Notified Bodies Push Back Hardest
A few recurring issues show up often enough in notified body feedback that they're worth knowing before you're the one defending a report. Equivalence claims draw particularly close scrutiny under MDR; reviewers expect a detailed, evidence-backed justification across technical, biological, and clinical characteristics, not a general statement that a device is "similar" to a predicate. Where access to the comparator device's own clinical data is limited, that gap has to be addressed directly in the report rather than glossed over, and in many cases it pushes a program toward generating its own clinical data instead of relying on equivalence at all.
Literature searches draw similar scrutiny. A search strategy has to be systematic and reproducible, with the search terms, databases, and date ranges documented, and the screening and appraisal of what comes back has to be consistent rather than selectively favorable to the device. Reviewers have gotten noticeably better at spotting a literature review that was built to support a predetermined conclusion rather than to genuinely evaluate the evidence, and reports that read that way tend to generate detailed, time-consuming queries back to the manufacturer. Building the search and appraisal process with real rigor from the start, even when it surfaces evidence that complicates the benefit-risk argument, tends to produce a cleaner review than trying to construct a tidier-looking narrative after the fact.
The benefit-risk conclusion itself is the other common friction point. It needs to follow logically from the evidence actually presented in the report, with any residual risks and their justification spelled out explicitly, rather than asserting a favorable conclusion that the preceding sections don't fully support. A specialist who treats the benefit-risk section as the place where the whole argument has to hold together, rather than a formality at the end of the document, produces reports that move through review faster.
How to Move Into This Role
If you're coming from a regulatory affairs background, the most direct path is to get involved in clinical evaluation work on whatever device programs you currently support, even in a supporting capacity, specifically to build hands-on literature review and MEDDEV methodology experience rather than treating the CER as something a separate clinical team owns. If you're coming from a medical writing or clinical research background, building familiarity with MDR's regulatory framework and Annex XIV specifically, not just general device regulatory knowledge, is what will make you credible for a CER-focused role rather than a general clinical writing position.
Either way, being able to speak concretely in an interview about how you've structured a literature search protocol, handled an equivalence argument, or incorporated PMCF data into an update, rather than describing clinical evaluation work in the abstract, is what distinguishes a candidate who has actually done this work from one who understands it conceptually. If you don't yet have direct experience, working through a published MEDDEV 2.7/1 Revision 4 example or a publicly available CER template in detail, and being able to discuss specifically where you'd expect notified body pushback, can substitute reasonably well for a first interview, even if it's no replacement for the real thing over time.
Conclusion
The clinical evaluation report specialist role exists because MDR demanded a level of rigor around clinical evidence that the device industry largely didn't have standing infrastructure for when the regulation took effect. That's made it a genuinely specialized function, sitting between regulatory strategy, clinical science, and scientific writing, with real ongoing demand both inside device companies and at the consultancies that support them. For regulatory and clinical professionals willing to build the specific combination of systematic literature review skill and MDR methodology fluency it requires, it's a well-defined, in-demand niche within the broader medical device regulatory field.